SOLARA ACTIVE PHARMA SCIENCES LIMITED — Capital/Financing Update 2025

Mar 26, 2025

Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block

27, Vandaloor Kelambakkam Road, Chennai – 600 127, India Tel : +91 44 43446700 Fax : +91 44 47406190 E-mail : investors@solara.co.in www.solara.co.in

Keelakottaiyur Village, Melakottaiyur (Post)

March 26, 2025

The BSE Limited

Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001 Scrip Code: 541540, 890202

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai – 400 051 Scrip Code: SOLARA, SOLARAPP

Dear Sir / Madam,

Sub: Announcement of Rights Issue Committee Meeting under Regulation 29 (1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”)

This is to inform you that further to our letter dated March 26, 2025, and pursuant to Regulations 29 of the SEBI Listing Regulations, the Company hereby informs the Exchange, on the meeting of Rights Issue Committee of the Board of Directors of the Company which is scheduled to be held on Wednesday, April 02, 2025, inter alia, to consider and approve the First Call money Notice, on the partly paid Equity Shares issued on Rights basis which is to be sent to the Shareholders.

This is for your information and appropriate dissemination.

Thanking you,

Yours faithfully,

For Solara Active Pharma Sciences Limited

SUDDAPALLI Digitally signed by SUDDAPALLI MURALIKRISHNA MURALIKRISHNA Date: 2025.03.26 16:13:40 +05'30'

S. Murali Krishna Company Secretary and Compliance Officer Membership No: A13372

Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942